UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment

Antimicrobial agents and chemotherapy, 2014-11, Vol.58 (11), p.6471-6476

2014

Volltextzugriff (PDF)

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients

Diabetes care, 1999-05, Vol.22 (5), p.789-794

1999

Volltextzugriff (PDF)

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension

Journal of human hypertension, 2003-06, Vol.17 (6), p.425-432

2003

Volltextzugriff (PDF)

The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1209-1220

2012

Volltextzugriff (PDF)

Pharmacokinetics of repaglinide in subjects with renal impairment

Clinical pharmacology and therapeutics, 2000-01, Vol.67 (1), p.7-15

2000

Volltextzugriff (PDF)

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes

Experimental and clinical endocrinology & diabetes, 2008-05, Vol.116 (5), p.282-288

2008

Volltextzugriff (PDF)

Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension

The journal of clinical hypertension (Greenwich, Conn.), 2001-09, Vol.3 (5), p.283-318

2001

Volltextzugriff (PDF)

Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval

Journal of clinical pharmacology, 2008-06, Vol.48 (6), p.726-733

2008

Volltextzugriff (PDF)

Flexible prandial glucose regulation with repaglinide in patients with Type 2 diabetes

Diabetes research and clinical practice, 1999-08, Vol.45 (1), p.31-39

1999

Volltextzugriff (PDF)

Anaritide in Acute Tubular Necrosis

The New England journal of medicine, 1997-03, Vol.336 (12), p.828-834

1997

Volltextzugriff (PDF)

Comparison of the Fixed Combination of Enalapril/Diltiazem ER and Their Monotherapies in Stage 1 to 3 Essential Hypertension

American journal of hypertension, 1998, Vol.11 (1), p.23-30

1998

Volltextzugriff (PDF)

Pharmacokinetics of Etoricoxib in Patients with Renal Impairment

Journal of clinical pharmacology, 2004-01, Vol.44 (1), p.48-58

2004

Volltextzugriff (PDF)

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

The New England journal of medicine, 2014-05, Vol.370 (21), p.1983-1992

2014

Volltextzugriff (PDF)

Quadriceps tendon ruptures in uremia

Clinical orthopaedics and related research, 1985-05, Vol.195 (195), p.200-206

1985

Volltextzugriff (PDF)

Effects and Tolerability of Irbesartan Versus Enalapril in Patients With Severe Hypertension

The American journal of cardiology, 1997-12, Vol.80 (12), p.1613-1615

1997

Volltextzugriff (PDF)

Evaluation of Enalapril Combined with Diltiazem Er in Patients with Stage 3-4 Essential Hypertension

Clinical and experimental hypertension (1993), 1998, Vol.20 (1), p.41-52

1998

Volltextzugriff (PDF)

A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis

Clinical therapeutics, 2002-02, Vol.24 (2), p.223-236

2002

Volltextzugriff (PDF)

Pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes

Diabetes technology & therapeutics, 1999, Vol.1 (3), p.247-256

1999

Volltextzugriff (PDF)

Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment

International journal of clinical pharmacology and therapeutics, 2017-09, Vol.55 (9), p.746

2017

Volltextzugriff (PDF)

The pharmacokinetics of peginterferon alfa‐2a and ribavirin in A frican A merican, H ispanic and C aucasian patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2012-05, Vol.35 (10), p.1209-1220

2012

Volltextzugriff (PDF)

THU0433 Pharmacodynamic and pharmacokinetic study of verinurad (RDEA3170) in adult male subjects with mild, moderate, and severe renal impairment: a phase 1, open-label study

Annals of the rheumatic diseases, 2017-06, Vol.76 (Suppl 2), p.371

2017

Volltextzugriff (PDF)

Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor

Clinical drug investigation, 2018-08, Vol.38 (8), p.703-713

2018

Volltextzugriff (PDF)

Pharmacokinetic profile of defibrotide in patients with renal impairment

Drug design, development and therapy, 2016-01, Vol.10, p.2631-2641

2016

Volltextzugriff (PDF)

Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction

Journal of clinical pharmacology, 2005-10, Vol.45 (10), p.1145-1152

2005

Volltextzugriff (PDF)

High-Dose, Short-Duration, Early Valacyclovir Therapy for Episodic Treatment of Cold Sores: Results of Two Randomized, Placebo-Controlled, Multicenter Studies

Antimicrobial Agents and Chemotherapy, 2003-03, Vol.47 (3), p.1072-1080

2003

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(223)
Mit Volltextzugriff
(166)

Publikationsform

Sprache

Englisch
(247)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics of tedizolid in subjects with renal or hepatic impairment

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients

Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension

The pharmacokinetics of peginterferon alfa-2a and ribavirin in African American, Hispanic and Caucasian patients with chronic hepatitis C

Pharmacokinetics of repaglinide in subjects with renal impairment

A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes

Comparative Efficacy of Olmesartan, Losartan, Valsartan, and Irbesartan in the Control of Essential Hypertension

Raltegravir Thorough QT/QTc Study: A Single Supratherapeutic Dose of Raltegravir Does Not Prolong the QTcF Interval

Flexible prandial glucose regulation with repaglinide in patients with Type 2 diabetes

Anaritide in Acute Tubular Necrosis

Comparison of the Fixed Combination of Enalapril/Diltiazem ER and Their Monotherapies in Stage 1 to 3 Essential Hypertension

Pharmacokinetics of Etoricoxib in Patients with Renal Impairment

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV

Quadriceps tendon ruptures in uremia

Effects and Tolerability of Irbesartan Versus Enalapril in Patients With Severe Hypertension

Evaluation of Enalapril Combined with Diltiazem Er in Patients with Stage 3-4 Essential Hypertension

A randomized, double-blind, multicenter comparison of gatifloxacin versus ciprofloxacin in the treatment of complicated urinary tract infection and pyelonephritis

Pharmacokinetics, pharmacodynamics, and dose-response relationship of repaglinide in type 2 diabetes

Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment

The pharmacokinetics of peginterferon alfa‐2a and ribavirin in A frican A merican, H ispanic and C aucasian patients with chronic hepatitis C

THU0433 Pharmacodynamic and pharmacokinetic study of verinurad (RDEA3170) in adult male subjects with mild, moderate, and severe renal impairment: a phase 1, open-label study

Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Verinurad, a Selective Uric Acid Reabsorption Inhibitor

Pharmacokinetic profile of defibrotide in patients with renal impairment

Pharmacokinetics of Micafungin in Healthy Volunteers, Volunteers With Moderate Liver Disease, and Volunteers With Renal Dysfunction

High-Dose, Short-Duration, Early Valacyclovir Therapy for Episodic Treatment of Cold Sores: Results of Two Randomized, Placebo-Controlled, Multicenter Studies

Suchergebnisse filtern